Company Quick10K Filing
Innospec
10-Q 2021-03-31 Filed 2021-05-05
10-K 2020-12-31 Filed 2021-02-17
10-Q 2020-09-30 Filed 2020-11-04
10-Q 2020-06-30 Filed 2020-08-05
10-Q 2020-03-31 Filed 2020-05-06
10-K 2019-12-31 Filed 2020-02-19
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-02-20
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-02-15
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-02-15
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-03
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-02-17
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-06
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-11-06
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-07
10-K 2012-12-31 Filed 2013-02-13
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-02-17
10-Q 2011-09-30 Filed 2011-11-02
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-02-18
10-Q 2010-09-30 Filed 2010-11-02
10-Q 2010-06-30 Filed 2010-08-04
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-02-19
8-K 2020-11-03
8-K 2020-11-03
8-K 2020-11-01
8-K 2020-09-16
8-K 2020-08-04
8-K 2020-05-06
8-K 2020-05-05
8-K 2020-03-01
8-K 2020-02-18
8-K 2020-02-17
8-K 2019-11-05
8-K 2019-09-26
8-K 2019-08-06
8-K 2019-07-01
8-K 2019-06-01
8-K 2019-05-24
8-K 2019-05-08
8-K 2019-05-07
8-K 2019-04-05
8-K 2019-02-19
8-K 2018-11-06
8-K 2018-08-07
8-K 2018-05-09
8-K 2018-05-08
8-K 2018-04-24
8-K 2018-03-12
8-K 2018-02-13

Innospec Financials

IOSP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 41 77% -17.5 -11% 226 289 73 56 -25 -14 243
Clovis Oncology (CLVS) 219 0% -0.0 -56% 717 804 134 0 -400 -394 18
Cementos Pacasmayo Saa (CPAC) 4,145 0% 2,863 1,412 0 0 0 0 4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 123 1.0 0% 962 869 0 0 3 15 14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash991327691106130224355548090919042466412813711315316710245496690786691123124106110
Accounts Receivable
Inventory142138136139140144138142150167159160173172185176168167160153155162174199218212210248252262248249248251
PP&E13513446137136140146144147155175158162160187186154158161166169174252278301313327321191195403200200195
Assets5725985695926036345795845946987957787877751,0009779981,0171,0301,0011,0311,0431,1811,2251,2771,3131,4101,4731,4511,4971,4731,5271,4901,494
Accounts Payable585353574355574747576354525288596767525051566098108116118128126127127124117106
Long-Term Debt33903536403430373393148140140115139139139127133146154143269239249229218214224224208208158131
Liabilities231286226223217231262250242322385351346317484455449429425382392391528549572565616648632657648678626612
Stockholders' Equity341312343369386403317334352376409427441458516522549588605619639652654676704748794824819840825848863882
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue186202200201178183214199185193242221221228291269243254246212228206238294415332354361358363388362372
Cost of Revenue128144143137116133149136112135167155144155197187155164160136142126146203298234245256255252270251253
Gross Profit58585864635165647257756677749482889086768679919111799108104108111118111119
R&D5555555666566656676766678888989810
SG&A307329282728343639324342484247495053554453565655616163676665727171
Tax5-807202-405442255156176468276974588101088
Net Income25-17202557161318201429172121281834363219291122173223-5222221292230
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating914181234-31820-630211347183736277503018-2094648-235135040
Cash Investing-2-4-4-3-4-59-4-3-60-49-3-5-106-7-635-72-3-5-203-7-6-9-8-5-9-11-6-7
Cash Financing27-6515-6-458-56546-8-710-5-12-8-11-32-7-11121-300-21-16-6-0-2-62-29